Last Updated: November 8, 2026

Details for Patent: 5,944,329

« Back to Dashboard


Summary for Patent: 5,944,329
Title:Reversible micromachining locator
Abstract:This invention provides a device which includes a locator, a kinematic mount positioned on a conventional tooling machine, a part carrier disposed on the locator and a retainer ring. The locator has disposed therein a plurality of steel balls, placed in an equidistant position circumferentially around the locator. The kinematic mount includes a plurality of magnets which are in registry with the steel balls on the locator. In operation, a blank part to be machined is placed between a surface of a locator and the retainer ring (fitting within the part carrier). When the locator (with a blank part to be machined) is coupled to the kinematic mount, the part is thus exposed for the desired machining process. Because the locator is removably attachable to the kinematic mount, it can easily be removed from the mount, reversed, and reinserted onto the mount for additional machining. Further, the locator can likewise be removed from the mount and placed onto another tooling machine having a properly aligned kinematic mount. Because of the unique design and use of magnetic forces of the present invention, positioning errors of less than 0.25 micrometer for each machining process can be achieved.
Inventor(s):Leander J. Salzer, Larry R. Foreman
Assignee: University of California San Diego UCSD
Application Number:US08/925,096
Patent Claim Types:
see list of patent claims
Device;
Patent landscape, scope, and claims:

United States Patent 5,944,329: Claim Scope, Validity, Expiration, and Patent Landscape

U.S. Patent No. 5,944,329 is not a drug patent. It covers a mechanical locator-and-mount apparatus for machining parts. The core invention combines a circumferential kinematic mount, alternating connection elements and grooves, and a reversible locator having projections that engage the grooves. The claims are directed to apparatus configurations rather than a method of machining, a particular workpiece, or a pharmaceutical product.

The patent’s commercial relevance is primarily historical. Its claim set is narrow in geometry and component arrangement, and its U.S. patent term has likely expired based on the 1990s filing and 1999 grant chronology. No Orange Book listing, FDA exclusivity, Paragraph IV pathway, biosimilar issue, or drug-related regulatory status applies.

What technology does U.S. Patent 5,944,329 protect?

The patent protects a modular workholding system for positioning parts during machining. Its architecture has two principal components:

  1. A kinematic mount.
  2. One or more removable locators that support a workpiece.

The mount uses grooves and connecting elements arranged around its circumference. The locator has projections on both of its opposing surfaces. The projections fit into the mount grooves, allowing the locator to be positioned with either surface facing the mount.

The claims indicate that the system is intended to provide repeatable positioning while allowing rapid locator replacement or reorientation. The claimed apparatus also supports configurations in which two locators are placed on the same mount at the same time.

What is the scope of independent claim 1?

Claim 1 is the principal scope-defining claim. It requires every element below:

Claim element Required limitation
Apparatus type Locator and mount apparatus for machining parts
Mount Kinematic mount
Mount surface Top surface
Mount connection structure Either a connecting means or structure receptive to a connecting means
Mount positioning structure Grooves
Arrangement Connecting or receptive structures and grooves alternate circumferentially
Locator At least one locator
Locator connection structure Either a connecting means or structure receptive to a connecting means
Workpiece interface Part support means
Locator positioning structure Multiple projections on both locator surfaces
Functional relationship Projections and grooves position the locator when disposed on the mount
Reversibility The locator can contact the mount with either surface

The claim is a combination claim. A device must contain the mount, locator, alternating circumferential arrangement, dual-sided projections, and projection-groove positioning relationship to fall within the literal scope of claim 1.

A conventional fixture with only one-sided locating features would not satisfy the express requirement for projections on both locator surfaces. A system using a flat plate and independent dowel pins may also avoid literal infringement if it lacks the claimed alternating circumferential connection and groove arrangement.

How do claims 2 through 11 narrow the patent scope?

Claims 2 through 11 add specific hardware configurations.

Claim Added limitation Scope effect
2 Magnets on the mount and magnet-attractive locator material Limits the system to magnetic retention
3 Rare-earth magnets Narrows claim 2 to rare-earth magnetic elements
4 V-grooves Requires V-shaped grooves
5 Three V-grooves at 120-degree intervals Requires a three-point radial pattern
6 Six V-grooves at 60-degree intervals Requires a six-point radial pattern
7 Adjustable magnet mounting system Adds magnet-position adjustment
8 Steel-ball projections Requires steel balls as projections
9 Three steel balls at 120-degree intervals Requires a three-point ball arrangement
10 Retainer ring as part support Limits the workpiece support structure
11 Part-support clamp Limits the support structure to a clamp arrangement

These claims are progressively narrower. For example, a system using permanent magnets but ceramic or non-steel locating projections may potentially avoid claim 8 while remaining within claim 2, assuming all claim 1 elements are present. A mount with six V-grooves may fall within claim 6 but not claim 5, which requires three V-grooves.

Claim 3 is narrower than claim 2 but does not necessarily require a particular rare-earth composition. The term “rare earth magnets” would ordinarily encompass commercially recognized rare-earth magnet types, subject to the specification and prosecution history.

What do claims 12 through 16 protect?

Claims 12 through 16 address dual-locator operation.

Claim 12 requires a first locator and a second locator that are simultaneously disposed on the same mount. This is a significant narrowing limitation because the claim is directed to concurrent use rather than merely the capability of using multiple interchangeable locators.

Claims 13 and 14 define the first locator. It must include:

  • A structure for carrying a part;
  • Multiple projections;
  • Multiple offset bosses;
  • Magnet-clearance holes;
  • Projection-clearance holes.

Claim 14 specifies three of each principal feature, arranged at 120-degree intervals.

Claims 15 and 16 define the second locator. The second locator must include:

  • A structure for carrying a part;
  • Multiple projections;
  • Multiple offset bosses;
  • Offset-boss clearance holes;
  • Projection-clearance holes.

Claim 16 specifies three of each feature, also arranged at 120-degree intervals.

The distinction between the first and second locator configurations appears to concern the location and function of clearance holes. The claimed holes permit two locators to occupy the mount simultaneously without interference from magnets, projections, or bosses.

What claim construction issues are likely to matter?

The following terms would likely control infringement analysis:

“Kinematic mount”

A kinematic mount generally constrains a workpiece or fixture through defined contact points and repeatable geometric constraint. The claim does not merely require a flat support plate. The accused mount would likely need a structure that provides repeatable positioning through the claimed grooves and projections.

“Alternating circumferentially”

This language requires a circumferential sequence in which connection or receptive structures alternate with grooves. A mount where all magnets are grouped in one area and all grooves in another may not satisfy this limitation.

“Projections on both locator surfaces”

The requirement applies to both opposing locator surfaces. Projections on only the working face are insufficient for literal claim 1 infringement.

“Either surface contacting said mount”

The locator must be usable with either surface against the mount. This limitation supports the patent’s reversible-locator concept.

“Connecting means” and “means receptive to a connecting means”

These phrases may invoke means-plus-function analysis under 35 U.S.C. § 112(f), depending on the specification and prosecution history. If so, the corresponding structure disclosed in the patent and its equivalents would define the enforceable scope. The specification would be essential to determine whether the claims cover only magnets and magnetically attractive materials or broader connection technologies.

“Part support means”

Claims 10 and 11 identify examples of the support structure, but claim 1 is broader. A retainer ring or clamp is not necessarily required by the independent claim unless the dependent claim is asserted.

What is the difference between literal infringement and the doctrine of equivalents?

Literal infringement requires the accused apparatus to satisfy every limitation of the asserted claim. For claim 1, the most important literal questions would be:

  • Does the mount have the required alternating circumferential pattern?
  • Are grooves present?
  • Are projections located on both locator surfaces?
  • Do the projections and grooves position the locator?
  • Can either locator surface contact the mount?
  • Does the apparatus have the claimed connecting or receptive structure?

The doctrine of equivalents could become relevant where an accused product uses a technically different structure that performs substantially the same function in substantially the same way to achieve substantially the same result. The “all elements” rule still applies. A substantial departure from the reversible dual-sided projection architecture could weaken an equivalence theory.

How strong is the patent estate?

The patent estate appears limited to a single U.S. patent and the claim set reproduced by the user. The claims are technically specific and structurally dense. That produces a mixed enforcement profile:

Factor Assessment
Core concept Clear and commercially understandable
Claim breadth Moderate to narrow
Design-around exposure High
Dependence on specific geometry High
Dependence on magnets Present in several dependent claims
Dependence on V-grooves Present in dependent claims
Dual-locator coverage Narrow and configuration-specific
Pharmaceutical relevance None
Current U.S. exclusionary value Likely none if the patent term has expired

Claim 1 is broader than the dependent claims but still requires a particular combination of circumferentially alternating structures and reversible dual-sided projections. Competitors could design around the claims by changing the locating interface, eliminating reversible use, using non-circumferential positioning elements, or using a different retention mechanism.

When did U.S. Patent 5,944,329 lose exclusivity?

The patent was granted on August 31, 1999. Its exact expiration date depends on the applicable patent-term regime, the earliest effective nonprovisional filing date, any patent-term adjustment, and any terminal disclaimer.

Because the patent originated from the 1990s, its term would ordinarily be calculated under the 20-year-from-effective-filing-date framework applicable to post-June 8, 1995 applications, unless an earlier priority or other term rule applies. A 1999 grant date alone does not establish the expiration date. The public patent record, including the front page, continuity data, and USPTO Patent Center, controls the final calculation. See 35 U.S.C. § 154 and USPTO, “Patent Term Calculator.”

The practical business conclusion is that a 1999-issued mechanical patent of this vintage is no longer a normal current blocking right unless an unusual term adjustment or other legally operative circumstance extended its term.

What is the FDA and Orange Book status?

U.S. Patent 5,944,329 has no FDA or Orange Book status because it does not claim a drug, active pharmaceutical ingredient, formulation, method of treatment, dosage form, biologic, or manufacturing process for a regulated medicine.

Regulatory category Status
FDA product approval Not applicable
Orange Book listing Not applicable
Hatch-Waxman exclusivity Not applicable
Paragraph IV challenge Not applicable
Biosimilar litigation Not applicable
REMS-related exclusivity Not applicable
Pediatric exclusivity Not applicable
Generic-drug launch risk Not applicable
Pharmaceutical formulation protection None

The patent cannot block an ANDA, 505(b)(2) application, or biosimilar application because its claims are unrelated to a pharmaceutical product.

What patent landscape surrounds the claimed technology?

The relevant landscape is mechanical workholding and precision fixturing rather than drug patents. Competing technologies would likely fall into these categories:

Kinematic and quasi-kinematic fixtures

These systems use defined contact points, balls, grooves, cones, pins, or other constrained interfaces to achieve repeatable repositioning. A competitor using a different contact geometry may avoid the specific projection-and-groove combination.

Magnetic workholding systems

Magnetic bases and ferromagnetic locators are central to claims 2, 3, and 7. Relevant competing designs may use vacuum retention, mechanical clamps, pneumatic retention, hydraulic clamping, or mechanical fasteners.

Modular fixture plates

Modular plates may support interchangeable nests, pallets, dowel systems, or locating blocks. A plate with fixed dowel-hole patterns may present a different claim profile from the circumferential alternating arrangement required by claim 1.

Reversible locator systems

The reversible feature is a central technical limitation. Systems with only one usable locator orientation may avoid the express dual-surface requirement.

Multi-part or dual-locator fixtures

Claims 12 through 16 focus on two locators used simultaneously. Competing systems may use separate independent mounts, linear indexing, stacked fixture plates, or non-overlapping nests.

What manufacturing and intellectual-property barriers remain?

The patent itself does not create a significant current manufacturing barrier if its U.S. term has expired. The principal barriers are likely engineering and commercial:

  • Precision machining of V-grooves and projection interfaces;
  • Repeatable magnet placement;
  • Control of magnetic force and workpiece interference;
  • Wear resistance at ball-and-groove contacts;
  • Tolerance control for interchangeable locators;
  • Clearance design for simultaneous locator use;
  • Protection of know-how relating to calibration and fixture setup.

A manufacturer could still face rights under later patents, foreign counterparts, unexpired continuation patents, design patents, trade secrets, or third-party rights covering improved fixture geometries. Those rights cannot be determined from the supplied claims alone.

Are there Paragraph IV challenges, settlements, or licensing deals?

No pharmaceutical Paragraph IV analysis applies. The supplied claim set does not identify any generic-drug challenger, biosimilar applicant, FDA sponsor, Hatch-Waxman litigation, or drug patent settlement.

A licensing assessment would require the patent’s assignment history, recorded licenses, security interests, litigation docket, and any related continuation or foreign-family filings. The claims alone do not establish whether the patent was licensed or commercially transferred.

What geographic coverage does the patent provide?

The patent claims provide U.S. rights only. Any protection outside the United States would require separately issued foreign patents or regional rights. A U.S. patent does not automatically create enforceable rights in Canada, Europe, Japan, China, or other jurisdictions.

Foreign family members, if any, would require separate review for:

  • Filing dates;
  • Grant status;
  • Claim scope;
  • Local expiration;
  • Maintenance-fee compliance;
  • Assignment and licensing;
  • Litigation and opposition history.

Key Takeaways

  • U.S. Patent 5,944,329 is a mechanical machining-fixture patent, not a drug patent.
  • Claim 1 requires a kinematic mount, alternating circumferential connection or receptive structures and grooves, and a reversible locator with projections on both surfaces.
  • Claims 2 through 11 narrow the system through magnets, rare-earth magnets, V-grooves, steel balls, retainer rings, clamps, and adjustable magnet mounts.
  • Claims 12 through 16 cover simultaneous use of two specially configured locators.
  • The claim set is structurally specific and has substantial design-around exposure.
  • FDA approval, Orange Book listing, Paragraph IV litigation, biosimilar risk, and pharmaceutical exclusivity do not apply.
  • The exact patent expiration date requires the official continuity and term records, but a 1999-issued patent of this type is unlikely to retain ordinary current U.S. exclusionary value.
  • Current freedom-to-operate analysis should focus on later patents, continuations, foreign family members, and competing fixture patents.

FAQs

Is U.S. Patent 5,944,329 a pharmaceutical patent?

No. It covers a locator and mount apparatus used to position parts during machining.

Can a magnetic fixture infringe U.S. Patent 5,944,329?

Potentially, but magnetic retention alone is insufficient. The fixture would also need to satisfy the applicable mount, groove, projection, circumferential arrangement, and reversible-locator limitations.

Does a three-point kinematic mount automatically infringe the patent?

No. Three-point geometry alone does not establish infringement. The accused system must satisfy all limitations of an asserted claim, including the claimed circumferential arrangement and dual-sided locator projections.

Do claims 12 through 16 cover any two fixtures used together?

No. They require specific first and second locator structures, including projections, offset bosses, clearance holes, and, in the narrower claims, three-part 120-degree arrangements.

Is a Paragraph IV certification required to challenge this patent?

No. Paragraph IV certifications apply to patents listed for approved drug products. This patent is directed to mechanical machining equipment and has no Orange Book function.

Sources:

  1. U.S. Patent No. 5,944,329, “Locator and Mount Apparatus for Machining Parts,” claims 1-16 (1999).

  2. United States Code, 35 U.S.C. § 154, “Contents and Term of Patent; Provisional Rights.”

  3. United States Patent and Trademark Office. (n.d.). “Patent term adjustment.” https://www.uspto.gov/patents/laws/patent-term-calculator

  4. U.S. Food and Drug Administration. (n.d.). “Approved drug products with therapeutic equivalence evaluations.” Orange Book. https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book

  5. United States Code, 35 U.S.C. § 112, “Specification.”

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 5,944,329

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.